Kupffer cells in the liver.
暂无分享,去创建一个
[1] C. Stephens,et al. Mechanisms of drug-induced liver injury , 2014, Current opinion in allergy and clinical immunology.
[2] J. Iredale,et al. Macrophages: central regulators of hepatic fibrogenesis and fibrosis resolution. , 2012, Journal of hepatology.
[3] M. Vidali,et al. Bias in macrophage activation pattern influences non-alcoholic steatohepatitis (NASH) in mice. , 2012, Clinical science.
[4] Anton P. McCaffrey,et al. Identifying Functional MicroRNAs in Macrophages with Polarized Phenotypes* , 2012, The Journal of Biological Chemistry.
[5] T. Roskams,et al. Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease , 2012, Nature Medicine.
[6] L. Kazdová,et al. Kupffer cells ameliorate hepatic insulin resistance induced by high-fat diet rich in monounsaturated fatty acids: the evidence for the involvement of alternatively activated macrophages , 2012, Nutrition & Metabolism.
[7] T. Luedde,et al. Hepatic macrophage migration and differentiation critical for liver fibrosis is mediated by the chemokine receptor C‐C motif chemokine receptor 8 in mice , 2012, Hepatology.
[8] A. Feldstein,et al. Caspase 1-mediated regulation of fibrogenesis in diet-induced steatohepatitis , 2011, Laboratory Investigation.
[9] N. Lanthier,et al. Kupffer cell depletion prevents but has no therapeutic effect on metabolic and inflammatory changes induced by a high‐fat diet , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[10] Hong-Yang Wang,et al. Nuclear factor high‐mobility group box1 mediating the activation of toll‐like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice , 2011, Hepatology.
[11] G. Natoli,et al. Transcriptional regulation of macrophage polarization: enabling diversity with identity , 2011, Nature Reviews Immunology.
[12] F. Kim,et al. Endothelial NO/cGMP/VASP Signaling Attenuates Kupffer Cell Activation and Hepatic Insulin Resistance Induced by High-Fat Feeding , 2011, Diabetes.
[13] A. Chawla,et al. Macrophage-mediated inflammation in metabolic disease , 2011, Nature Reviews Immunology.
[14] A. Mallat,et al. Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice , 2011, Hepatology.
[15] A. Feldstein,et al. Identification of a Cytochrome P4502E1/Bid/C1q-dependent Axis Mediating Inflammation in Adipose Tissue after Chronic Ethanol Feeding to Mice* , 2011, The Journal of Biological Chemistry.
[16] L. Nagy,et al. Redox signaling and the innate immune system in alcoholic liver disease. , 2011, Antioxidants & redox signaling.
[17] K. Clément,et al. Krüppel-like factor 4 regulates macrophage polarization. , 2011, The Journal of clinical investigation.
[18] Jonathan C. Cohen,et al. Human Fatty Liver Disease: Old Questions and New Insights , 2011, Science.
[19] F. Finkelman,et al. Local Macrophage Proliferation, Rather than Recruitment from the Blood, Is a Signature of TH2 Inflammation , 2011, Science.
[20] G. Arteel,et al. Plasminogen activator inhibitor-1 deficient mice are protected from angiotensin II-induced fibrosis. , 2011, Archives of biochemistry and biophysics.
[21] L. Nagy,et al. Early growth response (EGR)-1 is required for timely cell-cycle entry and progression in hepatocytes after acute carbon tetrachloride exposure in mice. , 2011, American journal of physiology. Gastrointestinal and liver physiology.
[22] Laura E Nagy,et al. Obesity, diabetes mellitus, and liver fibrosis. , 2011, American journal of physiology. Gastrointestinal and liver physiology.
[23] K. Kharbanda,et al. Ethanol feeding potentiates the pro-inflammatory response of Kupffer cells to cellular fibronectin. , 2011, Alcoholism, clinical and experimental research.
[24] P. Mandal,et al. Molecular Mechanism for Adiponectin-dependent M2 Macrophage Polarization , 2011, The Journal of Biological Chemistry.
[25] Manolito Torralba,et al. Enteric dysbiosis associated with a mouse model of alcoholic liver disease , 2011, Hepatology.
[26] G. Godlewski,et al. Endocannabinoids in liver disease , 2011, Hepatology.
[27] E. Ravussin,et al. The NALP3/NLRP3 Inflammasome Instigates Obesity-Induced Autoinflammation and Insulin Resistance , 2010, Nature Medicine.
[28] S. Sakaguchi,et al. Progression of alcoholic and non-alcoholic steatohepatitis: common metabolic aspects of innate immune system and oxidative stress. , 2011, Drug metabolism and pharmacokinetics.
[29] M. Morita,et al. Role of tumor-associated macrophages in the progression of hepatocellular carcinoma , 2011, Surgery Today.
[30] K. Kodys,et al. Up-regulation of MicroRNA-155 in Macrophages Contributes to Increased Tumor Necrosis Factor α (TNFα) Production via Increased mRNA Half-life in Alcoholic Liver Disease* , 2010, The Journal of Biological Chemistry.
[31] Percy A. Knolle,et al. Antigen-presenting cell function in the tolerogenic liver environment , 2010, Nature Reviews Immunology.
[32] L. Nagy,et al. Early growth response-1 attenuates liver injury and promotes hepatoprotection after carbon tetrachloride exposure in mice. , 2010, Journal of hepatology.
[33] A. Stavitsky,et al. Complement and alcoholic liver disease: role of C1q in the pathogenesis of ethanol-induced liver injury in mice. , 2010, Gastroenterology.
[34] I. Leclercq,et al. NFκB, cytokines, TLR 3 and 7 expression in human end‐stage HCV and alcoholic liver disease , 2010 .
[35] D. Brenner,et al. Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice. , 2010, Gastroenterology.
[36] L. Nagy,et al. Hepatic fibrosis is enhanced and accompanied by robust oval cell activation after chronic carbon tetrachloride administration to Egr-1-deficient mice. , 2010, The American journal of pathology.
[37] David M. Mosser,et al. Exploring the full spectrum of macrophage activation , 2010, Nature Reviews Immunology.
[38] P. Adegboyega,et al. Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis , 2010, BMC gastroenterology.
[39] G. Arteel,et al. PAI-1 plays a protective role in CCl4-induced hepatic fibrosis in mice: role of hepatocyte division. , 2010, American journal of physiology. Gastrointestinal and liver physiology.
[40] Z. Younossi,et al. Review: Treatment options for nonalcoholic fatty liver disease , 2010, Therapeutic advances in gastroenterology.
[41] Michael Müller,et al. Kupffer cells promote hepatic steatosis via interleukin‐1β–dependent suppression of peroxisome proliferator‐activated receptor α activity , 2010, Hepatology.
[42] H. Ginsberg,et al. C-C Chemokine Receptor 2 (CCR2) Regulates the Hepatic Recruitment of Myeloid Cells That Promote Obesity-Induced Hepatic Steatosis , 2010, Diabetes.
[43] Jun Hee Lee,et al. Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression , 2010, Cell.
[44] I. Leclercq,et al. NFkappaB, cytokines, TLR 3 and 7 expression in human end-stage HCV and alcoholic liver disease. , 2010, European journal of clinical investigation.
[45] J. Dubé,et al. Depletion of Liver Kupffer Cells Prevents the Development of Diet-Induced Hepatic Steatosis and Insulin Resistance , 2009, Diabetes.
[46] R. Pierce,et al. Loss of Kupffer cells in diet-induced obesity is associated with increased hepatic steatosis, STAT3 signaling, and further decreases in insulin signaling. , 2009, Biochimica et Biophysica Acta.
[47] L. Joosten,et al. The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity , 2009 .
[48] A. Keshavarzian,et al. Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats. , 2009, Alcoholism, clinical and experimental research.
[49] P. Turnbaugh,et al. The core gut microbiome, energy balance and obesity , 2009, The Journal of physiology.
[50] R. Rao. Endotoxemia and gut barrier dysfunction in alcoholic liver disease , 2009, Hepatology.
[51] J. Lamb,et al. The C3a Anaphylatoxin Receptor Is a Key Mediator of Insulin Resistance and Functions by Modulating Adipose Tissue Macrophage Infiltration and Activation , 2009, Diabetes.
[52] S. Kihara,et al. Adiponectin prevents progression of steatohepatitis in mice by regulating oxidative stress and Kupffer cell phenotype polarization , 2009, Hepatology research : the official journal of the Japan Society of Hepatology.
[53] Patrice D Cani,et al. Critical role of Kupffer cells in the management of diet-induced diabetes and obesity. , 2009, Biochemical and biophysical research communications.
[54] G. Baffy. Kupffer cells in non-alcoholic fatty liver disease: the emerging view. , 2009, Journal of hepatology.
[55] J. Kluwe,et al. Toll-like receptors as targets in chronic liver diseases , 2009, Gut.
[56] Zheng Shen,et al. Role of SIRT1 in regulation of LPS- or two ethanol metabolites-induced TNF-alpha production in cultured macrophage cell lines. , 2009, American journal of physiology. Gastrointestinal and liver physiology.
[57] N. Van Rooijen,et al. An early complement‐dependent and TLR‐4–independent phase in the pathogenesis of ethanol‐induced liver injury in mice , 2009, Hepatology.
[58] A. Keshavarzian,et al. Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats. , 2009, Journal of hepatology.
[59] R. Ray,et al. Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog , 2009, Proceedings of the National Academy of Sciences.
[60] N. Warner,et al. Function of Nod‐like receptors in microbial recognition and host defense , 2009, Immunological reviews.
[61] Min You,et al. Adiponectin and alcoholic fatty liver disease , 2008, IUBMB life.
[62] A. Chawla,et al. Mechanisms of macrophage activation in obesity-induced insulin resistance , 2008, Nature Clinical Practice Endocrinology &Metabolism.
[63] A. Dolganiuc,et al. The critical role of toll‐like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88 , 2008, Hepatology.
[64] V. Gordeuk,et al. Hepatic macrophage iron aggravates experimental alcoholic steatohepatitis. , 2008, American journal of physiology. Gastrointestinal and liver physiology.
[65] J. Reiser,et al. TRIF and IRF-3 Binding to the TNF Promoter Results in Macrophage TNF Dysregulation and Steatosis Induced by Chronic Ethanol1 , 2008, The Journal of Immunology.
[66] S. Friedman,et al. Mechanisms of hepatic fibrogenesis. , 2008, Gastroenterology.
[67] G. Arteel. New role of plasminogen activator inhibitor‐1 in alcohol‐induced liver injury , 2008, Journal of gastroenterology and hepatology.
[68] N. Chalasani,et al. Nonalcoholic fatty liver disease as a component of the metabolic syndrome , 2008, Current gastroenterology reports.
[69] Dominic P. Williams,et al. Understanding the role of reactive metabolites in drug-induced hepatotoxicity: state of the science. , 2008, Expert opinion on drug metabolism & toxicology.
[70] G. Arteel,et al. Early growth response-1 contributes to galactosamine/lipopolysaccharide-induced acute liver injury in mice. , 2007, American journal of physiology. Gastrointestinal and liver physiology.
[71] P. Adegboyega,et al. Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. , 2007, Journal of hepatology.
[72] S. Previs,et al. Chronic ethanol-induced insulin resistance is associated with macrophage infiltration into adipose tissue and altered expression of adipocytokines. , 2007, Alcoholism, clinical and experimental research.
[73] Frank Brombacher,et al. Macrophage-specific PPARγ controls alternative activation and improves insulin resistance , 2007, Nature.
[74] J. Fallowfield,et al. Scar-Associated Macrophages Are a Major Source of Hepatic Matrix Metalloproteinase-13 and Facilitate the Resolution of Murine Hepatic Fibrosis1 , 2007, The Journal of Immunology.
[75] A. Stavitsky,et al. Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice. , 2007, Gastroenterology.
[76] C. Day,et al. Genetics of Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease , 2007, Seminars in liver disease.
[77] P. Jares,et al. Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity. , 2007, Gastroenterology.
[78] A. Saltiel,et al. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. , 2007, The Journal of clinical investigation.
[79] K. Kharbanda,et al. Effect of chronic ethanol administration on the in vitro production of proinflammatory cytokines by rat Kupffer cells in the presence of apoptotic cells. , 2007, Alcoholism, clinical and experimental research.
[80] J. Flier,et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. , 2006, The Journal of clinical investigation.
[81] M. McCarthy,et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice , 2006, Proceedings of the National Academy of Sciences.
[82] V. Thakur,et al. Chronic ethanol feeding increases activation of NADPH oxidase by lipopolysaccharide in rat Kupffer cells: role of increased reactive oxygen in LPS‐stimulated ERK1/2 activation and TNF‐α production , 2006, Journal of leukocyte biology.
[83] D. Franchimont,et al. Differential liver sensitization to Toll‐like receptor pathways in mice with alcoholic fatty liver , 2006, Hepatology.
[84] B. Copple,et al. Early growth response factor-1 is critical for cholestatic liver injury. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[85] L. Diehl,et al. CRIg: A Macrophage Complement Receptor Required for Phagocytosis of Circulating Pathogens , 2006, Cell.
[86] R. Leibel,et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. , 2006, The Journal of clinical investigation.
[87] S. Meri,et al. Complement C3 contributes to ethanol‐induced liver steatosis in mice , 2006, Annals of medicine.
[88] G. Lewison,et al. Worldwide alcohol-related research and the disease burden. , 2006, Alcohol and alcoholism.
[89] N. Enomoto,et al. Ethanol-induced sensitization to endotoxin in Kupffer cells is dependent upon oxidative stress. , 2005, Alcoholism, clinical and experimental research.
[90] Jiahuai Han,et al. Limiting inflammatory responses during activation of innate immunity , 2005, Nature Immunology.
[91] S. Gordon,et al. Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.
[92] L. Romics,et al. Modulation of non-alcoholic steatohepatitis by pattern recognition receptors in mice: the role of toll-like receptors 2 and 4. , 2005, Alcoholism, clinical and experimental research.
[93] L. Nagy,et al. Ethanol-induced liver injury: potential roles for egr-1. , 2005, Alcoholism, clinical and experimental research.
[94] K. Hunt,et al. Synergistic enhancement of Toll‐like receptor responses by NOD1 activation , 2005, European journal of immunology.
[95] Jörg Köhl,et al. Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans , 2005, Nature Genetics.
[96] K. Mak,et al. Cytochrome P4502E1 primes macrophages to increase TNF-alpha production in response to lipopolysaccharide. , 2005, American journal of physiology. Gastrointestinal and liver physiology.
[97] C. Croniger,et al. Early growth response-1 transcription factor is essential for ethanol-induced fatty liver injury in mice. , 2005, Gastroenterology.
[98] L. Jacobs,et al. Nucleotide-Binding Oligomerization Domain-2 Modulates Specific TLR Pathways for the Induction of Cytokine Release 1 , 2005, The Journal of Immunology.
[99] S. Harrison,et al. Comparison of the natural history of alcoholic and nonalcoholic fatty liver disease , 2005, Current gastroenterology reports.
[100] K. Fukase,et al. Muramyldipeptide and diaminopimelic acid‐containing desmuramylpeptides in combination with chemically synthesized Toll‐like receptor agonists synergistically induced production of interleukin‐8 in a NOD2‐ and NOD1‐dependent manner, respectively, in human monocytic cells in culture , 2004, Cellular microbiology.
[101] P. Amenta,et al. The hepatic extracellular matrix , 1993, Virchows Archiv A.
[102] A. Hevener,et al. IKK-beta links inflammation to obesity-induced insulin resistance. , 2005, Nature medicine.
[103] L. Klassen,et al. Lipopolysaccharide is a cofactor for malondialdehyde-acetaldehyde adduct-mediated cytokine/chemokine release by rat sinusoidal liver endothelial and Kupffer cells. , 2004, Alcoholism, clinical and experimental research.
[104] P. Gasque. Complement: a unique innate immune sensor for danger signals. , 2004, Molecular immunology.
[105] R. Taub. Liver regeneration: from myth to mechanism , 2004, Nature Reviews Molecular Cell Biology.
[106] J. Suttles,et al. Functional plasticity of macrophages: reversible adaptation to changing microenvironments , 2004, Journal of leukocyte biology.
[107] T. Morgan,et al. Epidemiology of Alcoholic Liver Disease , 2004, Seminars in liver disease.
[108] D. Laskin,et al. Role of tumor necrosis factor receptor 1 (p55) in hepatocyte proliferation during acetaminophen-induced toxicity in mice. , 2003, Toxicology and applied pharmacology.
[109] C. Sempos,et al. Alcohol as a Risk Factor for Global Burden of Disease , 2003, European Addiction Research.
[110] L. Nagy. Recent Insights into the Role of the Innate Immune System in the Development of Alcoholic Liver Disease , 2003, Experimental biology and medicine.
[111] P. Gasque,et al. Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[112] G. Núñez,et al. Cell death and immunity: NODs: intracellular proteins involved in inflammation and apoptosis , 2003, Nature Reviews Immunology.
[113] M. Chamaillard,et al. Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection* , 2003, The Journal of Biological Chemistry.
[114] G. Arteel. Oxidants and antioxidants in alcohol-induced liver disease. , 2003, Gastroenterology.
[115] A. Ischenko,et al. Complement component anaphylatoxins upregulate chemokine expression by human astrocytes , 2003, FEBS letters.
[116] O. Götze,et al. Expression and induction of anaphylatoxin C5a receptors in the rat liver. , 2003, Histology and histopathology.
[117] S. Gordon. Alternative activation of macrophages , 2003, Nature Reviews Immunology.
[118] J. Brady,et al. Protective role of Kupffer cells in acetaminophen-induced hepatic injury in mice. , 2002, Chemical research in toxicology.
[119] T. F. Murray,et al. The Origin of the Synergistic Effect of Muramyl Dipeptide with Endotoxin and Peptidoglycan* , 2002, The Journal of Biological Chemistry.
[120] G. Bagby,et al. Sex differences in the modulation by ethanol of lung chemotaxis. , 2002, Alcohol.
[121] J. Hoek,et al. Ethanol, oxidative stress, and cytokine-induced liver cell injury. , 2002, Alcohol.
[122] M. McMullen,et al. Chronic Ethanol Increases Lipopolysaccharide-stimulated Egr-1 Expression in RAW 264.7 Macrophages , 2002, The Journal of Biological Chemistry.
[123] J. Kolls,et al. Alcohol, host defence and society , 2002, Nature Reviews Immunology.
[124] O. Götze,et al. Inhibition by prostaglandin E(2) of anaphylatoxin C5a- but not zymosan-induced prostanoid release from rat Kupffer cells. , 2002, Laboratory investigation; a journal of technical methods and pathology.
[125] Jeanette R. Hill,et al. ERK1/2 and Egr-1 contribute to increased TNF-alpha production in rat Kupffer cells after chronic ethanol feeding. , 2002, American journal of physiology. Gastrointestinal and liver physiology.
[126] I. Rusyn,et al. The role of Kupffer cell oxidant production in early ethanol-induced liver disease. , 2001, Free radical biology & medicine.
[127] M. McMullen,et al. Stabilization of tumor necrosis factor alpha mRNA by chronic ethanol: role of A + U-rich elements and p38 mitogen-activated protein kinase signaling pathway. , 2001, The Journal of biological chemistry.
[128] M. Walport. Complement. First of two parts. , 2001, The New England journal of medicine.
[129] O. Götze,et al. Functions of anaphylatoxin C5a in rat liver: direct and indirect actions on nonparenchymal and parenchymal cells. , 2001, International immunopharmacology.
[130] J. Kolls,et al. Prolonged ethanol treatment enhances lipopolysaccharide/phorbol myristate acetate-induced tumor necrosis factor-alpha production in human monocytic cells. , 2001, Alcoholism, clinical and experimental research.
[131] H. Tsukamoto,et al. Destabilization of TNF-alpha mRNA by retinoic acid in hepatic macrophages: implications for alcoholic liver disease. , 2001, American journal of physiology. Endocrinology and metabolism.
[132] H. Tilg,et al. Cytokines in alcoholic and nonalcoholic steatohepatitis. , 2000, The New England journal of medicine.
[133] A. Keshavarzian,et al. Exacerbation of alcoholic liver injury by enteral endotoxin in rats , 2000, Hepatology.
[134] S. Targan,et al. Tumor necrosis factor: biology and therapeutic inhibitors. , 2000, Gastroenterology.
[135] I. Rusyn,et al. NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease. , 2000, The Journal of clinical investigation.
[136] C. McClain,et al. Increased monocyte nuclear factor-kappaB activation and tumor necrosis factor production in alcoholic hepatitis. , 2000, The Journal of laboratory and clinical medicine.
[137] T. Mayadas,et al. Critical role of Kupffer cell CR3 (CD11b/CD18) in the clearance of IgM-opsonized erythrocytes or soluble beta-glucan. , 2000, Immunopharmacology.
[138] G. Szabo. Consequences of alcohol consumption on host defence. , 1999, Alcohol and alcoholism.
[139] N. Pumford,et al. Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen species , 1999, Hepatology.
[140] S. Maier,et al. Dynamic regulation of the proinflammatory cytokine, interleukin-1beta: molecular biology for non-molecular biologists. , 1999, Life sciences.
[141] D. Broide,et al. A comparison of C3a and C5a-mediated stable adhesion of rolling eosinophils in postcapillary venules and transendothelial migration in vitro and in vivo. , 1999, Journal of immunology.
[142] L. Nagy,et al. Ethanol dissociates hormone-stimulated cAMP production from inhibition of TNF-alpha production in rat Kupffer cells. , 1999, The American journal of physiology.
[143] Z. Younossi. EPIDEMIOLOGY OF ALCOHOL-INDUCED LIVER DISEASE , 1998 .
[144] R. Thurman,et al. II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin. , 1998, American Journal of Physiology - Gastrointestinal and Liver Physiology.
[145] Z. Spolarics,et al. Endotoxemia, pentose cycle, and the oxidant/antioxidant balance in the hepatic sinusoid , 1998, Journal of leukocyte biology.
[146] Makoto Naito,et al. Development, differentiation, and maturation of Kupffer cells , 1998, Microscopy research and technique.
[147] B. Beutler. TNF, immunity and inflammatory disease: lessons of the past decade. , 1995, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.
[148] Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen , 1995, Hepatology.
[149] A. Gressner,et al. Molecular mechanisms of liver fibrogenesis--a homage to the role of activated fat-storing cells. , 1995, Digestion.
[150] H. K. Bojes,et al. Inactivation of Kupffer cells prevents early alcohol‐induced liver injury , 1994, Hepatology.
[151] R. Raghow,et al. The role of extracellular matrix in postinflammatory wound healing and fibrosis , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[152] A. Nanji,et al. Severity of liver injury in experimental alcoholic liver disease. Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2. , 1993, The American journal of pathology.
[153] C. McClain,et al. Tumor necrosis factor in alcohol enhanced endotoxin liver injury. , 1992, Alcoholism, clinical and experimental research.
[154] C. Jacob. Tumor necrosis factor α in autoimmunity: pretty girl or old witch? , 1992 .
[155] C. Jacob. Tumor necrosis factor alpha in autoimmunity: pretty girl or old witch? , 1992, Immunology today.
[156] C. Bode,et al. Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay. , 1991, Journal of hepatology.
[157] A. Khoruts,et al. Circulating tumor necrosis factor, interleukin‐1 and interleukin‐6 concentrations in chronic alcoholic patients , 1991, Hepatology.
[158] M. Kazatchkine,et al. Human liver Kupffer cells express CR1, CR3, and CR4 complement receptor antigens. An immunohistochemical study. , 1989, Laboratory investigation; a journal of technical methods and pathology.
[159] C. McClain,et al. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis , 1989, Hepatology.
[160] C. Bode,et al. Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. , 1987, Journal of hepatology.